|
Blog Description FDA Scientist Questions Need for COX-2 Drugs
By Susan Heavey and Lisa Richwine
WASHINGTON (Reuters) Feb 17 - A veteran U.S. Food and Drug Administration scientist on Thursday said he saw no need for COX-2 inhibitors, citing increased vascular risks.
The presentation by David Graham, associate director for science and medicine at the FDA's Office of Drug Safety, came on the second day of an unusual three-day meeting called by the FDA after Merck & Co. pulled Vioxx (rofecoxib) from the market in late September. The recall was prompted by a study showing the drug doubled the risk of MI and stroke.
|
With evey fiber of my being, I must keep this blog alive. It may save lives.
more... Last Activity: 19 y ago 2 Messages Last message 19 y ago 1 Comments Last comment 19 y ago viewed 25,433 times Created: 19 y Feb 24 2005 |
CureZone Newsletter is distributed in partnership with https://www.netatlantic.com Contact Us - Advertise - Stats Copyright 1999 - 2024 www.curezone.org
0.046 sec, (2) |